future pharma

The future of healthcare lies in truly personalised patient and HCP journeys and conversations like this one help us all get there faster.

future pharma is a technology podcast hosted by RoseRx, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

RoseRx hosts future pharma, a technology show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  future pharma

  Leading with empathy, with David Henderson at Takeda

  Mar 31, 202636 minS0

  <p>Send us Fan Mail</p><p>Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with <b>David Henderson</b>, Franchise Head Specialty Oceania at Takeda, who brings over 20 years of biopharmaceutical leadership experience including 13 years at Biogen where he rose to Managing Director for Australia and New Zealand.<br/><br/>They explore what it means to lead with empathy in a digital age, how leadership approaches shift across international markets, and the cultural shifts toward personalized healthcare and patient segmentation. David discusses his bold call for Medical Affairs to move beyond the "zone of science" and become "...

  ListenShow Notes
• 

  future pharma

  From crawl to run: The reality of AI implementation in pharma with Arthur Alston

  Mar 17, 20261h 1mS0

  <p>Send us Fan Mail</p><p>Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with Arthur Alston, Head of Solid Tumours and Radioligand Therapy at Novartis Australia and New Zealand, who brings over 25 years of life sciences experience as both a trained physician and commercial leader. </p><p>They explore Arthur's "Crawl, Walk, Run" framework for AI adoption, why most pharma companies are still crawling despite buying licenses and the brutal realities of moving from enthusiasm to actual implementation.<br/><br/>Arthur shares practical insights on building AI agents across multiple functions, the limitations of RAG architecture i...

  ListenShow Notes
• 

  future pharma

  Pharma’s next era with Josie Downey at Merck Healthcare ANZ

  Feb 4, 202648 minS0

  <p>Send us Fan Mail</p><p>‘Not intended for US or Canadian viewers’.<br/><br/>Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with <b>Josie Downey</b><b>,</b> Managing Director of Merck Healthcare Australia and New Zealand, who brings 25 years of pharmaceutical experience, having successfully established businesses across APAC and launching life changing iconic brands. She is driven to improve the lives of patients through a relentless pursuit of solving access challenges to ensure that no patient is left behind.<br/><br/>They explore the difference between precision and personalised medicine, and confront the uncomfortable real...

  ListenShow Notes
• 

  future pharma

  AI, privacy and the red line in healthcare with Phil O'Sullivan at Allens

  Dec 11, 202547 minS0

  <p>Send us Fan Mail</p><p>This episode of future pharma tackles the fast-evolving world of privacy, regulation and AI in healthcare with Phil O’Sullivan, partner at commercial law firm Allens.<br/><br/>Phil explains how Australia’s principles-based Privacy Act is shifting, with much tougher penalties (including percentages of turnover) and growing expectations around governance, transparency, and use of patient data, especially as AI and LLMs move deeper into clinical support and patient-facing tools.<br/><br/>He draws a clear “red line” where technology starts to replace, rather than simply assist, clinicians and unpacks what that means for liab...

  ListenShow Notes
• 

  Episode #1

  Pharma's AI opportunity with AJ Rollsy at HealthPoint Research

  Nov 25, 202537 minS1

  <p>Send us Fan Mail</p><p>Future pharma host, Romain Bonjean, CEO of RoseRx, sits down with AJ Rollsy, founder and Managing Director of HealthPoint Research, who brings 25 years of global pharma and sales experience.<br/><br/>They explore how AI is reshaping patient and HCP engagement, the tension between innovation and governance, the emotional and behavioural drivers behind health decisions and what pharma can learn from other industries, using examples from GLP-1 weight management, DTC models and global market nuances.<br/><br/>AJ also shares where he thinks AI will genuinely add value for clinicians by reducing admin...

  ListenShow Notes

Recent guests on future pharma. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.